279 related articles for article (PubMed ID: 8908630)
1. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
Podoleanu D; Cotoi S
Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
[TBL] [Abstract][Full Text] [Related]
2. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
[TBL] [Abstract][Full Text] [Related]
3. Experience with ketanserin and ritanserin in hypertensive patients.
Hedner T; Persson B
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
[TBL] [Abstract][Full Text] [Related]
4. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
[TBL] [Abstract][Full Text] [Related]
5. [Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin].
Prostran M
Srp Arh Celok Lek; 1994; 122(3-4):99-102. PubMed ID: 17972821
[TBL] [Abstract][Full Text] [Related]
6. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension].
Poletti L; Fogari R; Bressan MA; Poggio M; Daglio M; Ripamonti L; Vlacos D; Azzaretti G
Clin Ter; 1993 Sep; 143(3):213-7. PubMed ID: 8222552
[TBL] [Abstract][Full Text] [Related]
8. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
[TBL] [Abstract][Full Text] [Related]
9. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of antagonist of S2-receptors.
Petkovská N; Brimichová G; Tison P; Dzúrik R
Czech Med; 1984; 7(4):210-4. PubMed ID: 6084584
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
13. [The effect of pharmacologic blockade of serotonin receptors (S2) on arterial pressure in rats with 2 forms of hereditary arterial hypertension].
Popova NK; Piianzin AI; Markel' AL
Farmakol Toksikol; 1989; 52(6):58-61. PubMed ID: 2516487
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
Sechi LA
Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
[TBL] [Abstract][Full Text] [Related]
15. [Role of ketanserin in the treatment of arterial hypertension].
Cricco L
Clin Ter; 1990 Aug 15-31; 134(3-4):199-203. PubMed ID: 2147621
[TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
17. Ketanserin (S2-receptor blocking agents), hypertension and chronic alcoholism.
De Lorenzo A; Ceccanti M; Romeo M; Pisculli M; Di Giovanni MG; Lais A; Assogna G; Valgiusti FC
Int J Clin Pharmacol Res; 1986; 6(1):77-9. PubMed ID: 2937747
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
Kay R; Poon WS; Nicholls MG
J Hum Hypertens; 1993 Aug; 7(4):369-71. PubMed ID: 8410928
[TBL] [Abstract][Full Text] [Related]
19. [Ketanserin and metoprolol in the treatment of essential hypertension].
Cerasola G; Contorno A; D'Ignoto G; Talamo AR; Vallone A; Zilietti T
Clin Ter; 1990 Aug 15-31; 134(3-4):193-7. PubMed ID: 2147620
[TBL] [Abstract][Full Text] [Related]
20. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
Bühler FR; Amstein R
Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
